Abstract:Abstract Understanding the evolutionary history of distant metastasis in Nasopharyngeal carcinoma (NPC) is important for curing NPC and has not been systematically investigated to date. Here, we profiled whole exomes/genomes of 142 bulk samples, and transcriptomes of 60 bulk samples from 42 NPC patients with matched primary tumor, and regional lymph node/distant metastasis tumor tissues. Among them, 55755 single cells from 2 patients was also sequenced. In addition, we analyzed radiomic data from 600 NPC patients. We observed that NPC primary, regional lymph node metastasis and distant metastasis tumors had concordant mutation profiling and intratumor heterogeneity. Furthermore, we found the genetic events selected during metastasis were enriched in pathways related to metastasis, such angiogenesis, Notch and Wnt signaling. Some critical genetic events were identified, such as mutations in FAT1, RPLP1, TET2, NFKBIA, NOTCH1/3 and ARID1A, copy number variations in NOTCH2 and ARID1A. According to the mutation based phylogenetic tree and single cell RNA-Seq data, two distinct dissemination routes of distant metastases were observed, including lymphatic dissemination from regional lymph node metastases and hematogenous dissemination from primary tumors. We observed that the two different metastatic dissemination routes had different genetic mechanisms revealed by profound genomic and transcriptomic evidence. The hematogenous and lymphatic route had distinct mutation signatures, where hematogenous route was significantly enriched with higher DNA mismatch repair related mutation signature compared to lymphatic route. The bulk and single cell RNA-Seq data showed that the lymphatic route had higher activity of Epithelial-mesenchymal transition (EMT) signaling, while the hematogenous route was characterized by higher expression of INF-γ response genes and higher fraction of exhausted CD8+ T cells. Moreover, the two dissemination routes exhibited evidently different clinical outcomes. The radio image data showed that the hematogenous and lymphatic routes significantly differed in the size of primary lesion, and the range of involved lymph nodes. The radiomic data further indicated that the hematogenous and lymphatic routes could be clearly separated according to radiomic features. By applying the radiomic model to a larger cohort, we found hematogenous route had poorer survival outcome compared to lymphatic route. Finally, at cellular resolution, we observed the primary tumor cells could be separated into two distinct clones, including non-metastatic clone and metastatic-like clone. The metastatic-like clone was characterized by a significant reduction of a ribosomol protein, RPL22. We experimentally confirmed that the reduction of RPL22 could activate NFKB pathway, thereby promoting NPC cell metastasis. Citation Format: Ming Yuan Chen, Zhi-Xiang Zuo, Rui You, Xiao-Long Zhang, Mei Lin. Tracking the evolution of nasopharyngeal carcinoma metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 3782.

Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma.

Enhanced Nuclear Translation is Associated with Proliferation and Progression Across Multiple Cancers

TERC Promotes Non-Small Cell Lung Cancer Progression by Facilitating the Nuclear Localization of TERT

[Expression of Telomerase Subunits and Its Relationship with Telomerase Activity in Nasopharyngeal Carcinoma].

Expression of Telomerase Subunits in Nasopharyngeal Carcinoma

Nucleolar localization of TERT is unrelated to telomerase function in human cells.

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population

TERT Drives Fibroblasts Reprogramming to Promote the Invasion of Head and Neck Squamous Cell Carcinoma Via Transferring of Exosomal MET Protein

The Role of Telomere, Telomerase and Its Htr in Nasopharyngeal Carcinoma

TEL2 Suppresses Metastasis by Down-Regulating SERPINE1 in Nasopharyngeal Carcinoma.

Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy

Abstract 3782: Tracking the evolution of nasopharyngeal carcinoma metastasis

Telomerase Reverse Transcriptase Mediates EMT Through NF-κB Signaling in Tongue Squamous Cell Carcinoma

Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance

Telomerase Reverse Transcriptase Methylation Predicts Lymph Node Metastasis And Prognosis In Patients With Gastric Cancer

Rapid detection of telomerase expression of neuroblastoma in paraffin-embedded tissue: combination of in situ hybridisation and quantitative PCR

Promoter Mutations and Cellular Distribution of Telomerase in Non-Clear Cell and Clear Cell Hepatocellular Carcinoma

P-150 * RECURRENT TELOMERASE REVERSE TRANSCRIPTASE PROMOTER MUTATIONS IN NON-SMALL-CELL LUNG CANCERS

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution

Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements